DGE analysis revealed 11, 9, and 30 genes differentially expressed between patients who survived versus those who succumbed to COVID-19 (log2 fold-change > 0.58) in CD14 monocytes, CD16 monocytes, and cDC2 cells, respectively. This evidence concerns the gene CD14 and COVID-19.